Mitochondrial and metabolic dysfunction in Friedreich ataxia: update on pathophysiological relevance and clinical interventions
Neuronal Signaling · 25.06.2021 · 5 (2)
DOI: 10.1042/ns20200093 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neuronal Signaling, online erschienen am 17.05.2021. Verfasst von David R Lynch und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurology, Departments of Neurology and Pediatrics, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicin…. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Friedreich ataxia (FRDA) is a recessive disorder resulting from relative deficiency of the mitochondrial protein frataxin. Frataxin functions in the process of iron–sulfur (Fe–S) cluster synthesis. In this review, we update some of the processes downstream of frataxin deficiency that may mediate the pathophysiology. Based on cellular models, in vivo models and observations of patients, ferroptosis may play a major role in the pathogenesis of FRDA along with depletion of antioxidant reserves and abnormalities of mitochondrial biogenesis. Ongoing clinical trials with ferroptosis inhibitors and nuclear factor erythroid 2-related factor 2 (Nrf2) activators are now targeting each of the processes. In addition, better understanding of the mitochondrial events in FRDA may allow the development of improved imaging methodology for assessing the disorder. Though not technologically feasible at present, metabolic imaging approaches may provide a direct methodology to understand the mitochondrial changes occurring in FRDA and provide a methodology to monitor upcoming trials of frataxin restoration.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Neurology, Departments of Neurology and Pediatrics, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, U.S.A.
Zitieren
APA
Lynch, D. R., & Farmer, G. (2021). Mitochondrial and metabolic dysfunction in Friedreich ataxia: update on pathophysiological relevance and clinical interventions. Neuronal Signaling, 5(2). https://doi.org/10.1042/ns20200093
Vancouver
Lynch DR, Farmer G. Mitochondrial and metabolic dysfunction in Friedreich ataxia: update on pathophysiological relevance and clinical interventions. Neuronal Signaling. 2021;5(2). doi:10.1042/ns20200093
BibTeX
@article{Lynch2021,
author = {Lynch, David R and Farmer, Garrett},
title = {Mitochondrial and metabolic dysfunction in Friedreich ataxia: update on pathophysiological relevance and clinical interventions},
journal = {Neuronal Signaling},
year = {2021},
volume = {5},
number = {2},
doi = {10.1042/ns20200093}
}
EUVIMED